Document is current
Any future updates will be listed below
-
Authors
Lissak, India A.
Locascio, Joseph J.
Zafar, Sahar F.
Schleicher, Riana L.
Patel, Aman B.
Leslie-Mazwi, Thabele
Stapleton, Christopher J.
Koch, Matthew J.
Kim, Jennifer A.
Anderson, Kasey
Rosand, Jonathan
Westover, M. Brandon
Kimberly, W. Taylor
Rosenthal, Eric S. https://orcid.org/0000-0003-3900-356X
-
Funding
Funding for this research was provided by:
NIH/NINDS (K23NS10595)
- License Information
-
More Information
Article History
Received: 21 August 2020
Accepted: 4 December 2020
First Online: 22 January 2021
Ethical approval
: The authors have adhered to ethical guidelines, and this study was approved by the institutional IRB.
: India Lissak has nothing to disclose. Dr. Locascio has nothing to disclose. Dr. Zafar reports grants from Sage therapeutics, grants from K23NS114201, outside the submitted work. Riana Schleicher has nothing to disclose. Dr. Patel reports personal fees from Penumbra, personal fees from Microvention, personal fees from Medtronic, outside the submitted work. Dr. Leslie-Mazwi has nothing to disclose. Dr. Stapleton has nothing to disclose. Dr. Koch has nothing to disclose. Dr. Kim has nothing to disclose. Kasey Anderson has nothing to disclose. Dr. Rosand reports grants from National Institutes of Health, grants from OneMind for Research, grants from American Heart Association, personal fees from Boehringer Ingelheim, outside the submitted work. Dr. Westover reports grants from NIH, during the conduct of the study. Dr. Kimberly reports grants and personal fees from Biogen, grants and personal fees from NControl Therapeutics, outside the submitted work; In addition, Dr. Kimberly has a patent 62/460,229 licensed to NControl Therapeutics. Dr. Rosenthal reports personal fees from UCB Pharmaceuticals, personal fees from Ceribell, Inc, grants from Department of Defense, outside the submitted work.
